Moderna (MRNA) EBITDA Margin (2018 - 2026)
Moderna (MRNA) recorded EBITDA Margin of -518.62% in Q2 2026, up 79.97 percentage points from -598.59% a year earlier but down 176.98 percentage points from the prior quarter.
Powered by 
Analysis
Moderna (MRNA) EBITDA Margin (2018 - 2026) Analysis & Trends
On a TTM basis, Moderna's EBITDA Margin came in at -138.20% as of Jun 30, 2026, down 38.62 percentage points year-over-year; for FY2025, it was -147.07%, down 31.00 percentage points from FY2024.
- Annual EBITDA Margin has declined for four straight years, with a five-year change of -55.91 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -116.07% in FY2024 (-63.24 pp), -52.83% in FY2023 (-103.54 pp), 50.71% in FY2022 (-22.53 pp) and 73.24% in FY2021 (+164.40 pp).
- Quarterly EBITDA Margin has ranged from -936.11% in Q1 2025 to 76.11% in Q4 2021 over the past five years.
- On a year-over-year basis, EBITDA Margin has increased for three consecutive quarters, with an average year-over-year change of +47.09 percentage points over the last eight quarters.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 594.47 percentage points in Q1 2026, against a drop of 721.06 percentage points in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -341.65% (Q1 2026), -116.52% (Q4 2025) and -20.47% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 42.49% |
| 10 | Moderna | 100.92 Bn | 80.27 Bn | 52.00 Mn | -518.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -518.62% |
| Mar 31, 2026 | -341.65% |
| Dec 31, 2025 | -116.52% |
| Sep 30, 2025 | -20.47% |
| Jun 30, 2025 | -598.59% |
| Mar 31, 2025 | -936.11% |
| Dec 31, 2024 | -122.77% |
| Sep 30, 2024 | -0.97% |
| Jun 30, 2024 | -548.55% |
| Mar 31, 2024 | -736.53% |
| Dec 31, 2023 | 7.40% |
| Sep 30, 2023 | -96.29% |
| Jun 30, 2023 | -515.99% |
| Mar 31, 2023 | -15.47% |
| Dec 31, 2022 | 32.65% |
| Sep 30, 2022 | 38.02% |
| Jun 30, 2022 | 53.13% |
| Mar 31, 2022 | 70.99% |
| Dec 31, 2021 | 76.11% |
| Sep 30, 2021 | 73.01% |
API Access
Moderna EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MRNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();